Abbott rises after raising annual profit forecast on heart device demand

** Shares of Abbott Laboratories ABT.N up 2.43% at $91.44 premarket

** Co raises 2026 adjusted profit forecast to $5.45-$5.60/shr from prior view of $5.38-$5.58/shr, above analysts' average estimate of $5.49/shr - LSEG data

** Demand for Abbott's heart devices expected to remain strong in the second half of the year, ABT says

** Co reports Q2 adj. profit of $1.31/shr vs estimates of $1.28/shr

** Co's quarterly revenue of $12.6 billion beats expectations of $12.5 billion

** As of last close, stock down ~29% YTD